BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ravid JD, Leiva O, Chitalia VC. Janus Kinase Signaling Pathway and Its Role in COVID-19 Inflammatory, Vascular, and Thrombotic Manifestations. Cells 2022;11:306. [DOI: 10.3390/cells11020306] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Leiva O, Campia U, Snyder J, Barns BM, Rizzo S, Khairani CD, Brunner A, Al-Samkari H, Leaf RK, Rosovsky R, Goodarzi K, Bornikova L, Fathi A, Goldhaber SZ, Hobbs G, Piazza G. Patients with myeloproliferative neoplasms and COVID-19 have increased rates of arterial thrombosis. Res Pract Thromb Haemost 2022;6:e12752. [PMID: 35979196 DOI: 10.1002/rth2.12752] [Reference Citation Analysis]
2 Russo A, Morrone HL, Rotundo S, Trecarichi EM, Torti C. Cytokine Profile of Invasive Pulmonary Aspergillosis in Severe COVID-19 and Possible Therapeutic Targets. Diagnostics 2022;12:1364. [DOI: 10.3390/diagnostics12061364] [Reference Citation Analysis]
3 Nazari-Khanamiri F, Ghasemnejad-Berenji M. A hypothesis that Notopterol may be effective in COVID-19 via JAK/STAT and other signaling pathways. J Basic Clin Physiol Pharmacol 2022. [PMID: 35390234 DOI: 10.1515/jbcpp-2022-0028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Georgakopoulou VE, Lembessis P, Skarlis C, Gkoufa A, Sipsas NV, Mavragani CP. Hematological Abnormalities in COVID-19 Disease: Association With Type I Interferon Pathway Activation and Disease Outcomes. Front Med 2022;9:850472. [DOI: 10.3389/fmed.2022.850472] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]